Symbol="CDTX"
AssetType="Common Stock"
Name="Cidara Therapeutics Inc"
Description="Cidara Therapeutics, Inc., a biotechnology company, is focused on the discovery, development, and commercialization of new long-acting anti-infectives for the treatment and prevention of disease in the United States. The company is headquartered in San Diego, California."
CIK="1610618"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="6310 NANCY RIDGE DRIVE, SUITE 101, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="99028000"
EBITDA="-8344000"
PERatio="None"
PEGRatio="0"
BookValue="0.298"
DividendPerShare="0"
DividendYield="0"
EPS="-0.13"
RevenuePerShareTTM="1.147"
ProfitMargin="-0.0999"
OperatingMarginTTM="-0.102"
ReturnOnAssetsTTM="-0.0774"
ReturnOnEquityTTM="-0.523"
RevenueTTM="83169000"
GrossProfitTTM="-11232000"
DilutedEPSTTM="-0.13"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="2.656"
AnalystTargetPrice="6"
TrailingPE="-"
ForwardPE="1.785"
PriceToSalesRatioTTM="0.569"
PriceToBookRatio="3.949"
EVToRevenue="0.276"
EVToEBITDA="0.471"
Beta="1.258"
num_52WeekHigh="2.1"
num_52WeekLow="0.46"
num_50DayMovingAverage="1.192"
num_200DayMovingAverage="1.052"
SharesOutstanding="90025000"
DividendDate="None"
ExDividendDate="None"
symbol="CDTX"
open="1.11"
high="1.12"
low="1.09"
price="1.10"
volume="593257.00"
latest_trading_day="2023-07-14"
previous_close="1.13"
change="-0.03"
change_percent="-2.6549%"
aroon_positive_momentum_days="59"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="59"
Volume_recent_avg="2221848"
Change_recent_avg="-0.01"
Delta_recent_avg="0.12"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-0.61"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="59"
Aroon_momentum_negative="41"
image_negative_thumbnail_id_1="140"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0036.jpeg"
image_negative_thumbnail_id_2="122"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0054.jpeg"
image_neutral_thumbnail_id_1="530"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0069.jpeg"
image_neutral_thumbnail_id_2="550"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0049.jpeg"
image_positive_thumbnail_id_1="951"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0113.jpeg"
image_positive_thumbnail_id_2="640"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0068.jpeg"
image_professor_thumbnail_id_1="1175"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
image_professor_thumbnail_id_2="1197"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
